Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Release Date: 09/11/2024
Neurology Minute
Dr. Irfan Sheikh explores a newly released NeuroByte episode, providing an insightful overview of how AI technologies, including ambient intelligence, can streamline documentation processes and enhance the efficiency of clinical practices. Show references:
info_outline Monoclonal Antibody to PACAP for Migraine Prevention - Part 2Neurology Minute
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention. Show reference:
info_outline Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to InterveneNeurology Minute
Dr. Rae Bacharach discusses the Neurology Today article, "Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene?" by Gina Shaw, available in the September 5th issue of Neurology Today or at . Show reference:
info_outline Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to InterveneNeurology Minute
Dr. Rae Bacharach discusses the Neurology Today article, "Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene?" by Gina Shaw, available in the September 5th issue of Neurology Today or at . Show reference:
info_outline Monoclonal Antibody to PACAP for Migraine Prevention - Part 1Neurology Minute
In the first installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina explore the biology of PACAP, its significance in relation to migraines, and its potential as a novel therapeutic approach. Show reference:
info_outline Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIHNeurology Minute
Dr. Amy Gelfand and Dr. Matthew Bender discuss the possible association between glymphatic outflow and extent of TSS in patients with IIH. Show reference:
info_outline Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine ProdromeNeurology Minute
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at . Show reference:
info_outline Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis RelapsesNeurology Minute
Dr. Rae Bacharach discusses the Neurology Today article, "Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses" by Susan FitzGerald, available in the September 5th issue of Neurology Today or at . Show reference:
info_outline Spinal Muscular Atrophy Update in Best Practices - Part 3Neurology Minute
In the third episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the critical objective of advancing the quality of life for individuals with SMA in the coming years. Show reference:
info_outline Specialist Physiotherapy for Functional Motor DisorderNeurology Minute
Dr. David Perez and Dr. Glenn Nielsen discuss the effectiveness of physiotherapy in treating functional motor disorder and to determine the best approach for physiotherapy treatment. Show reference:
info_outlineDr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org.
Show reference: